Vertex Aerospace will continue to beneficially own 10,167,286 shares, or ~32.3% of V2X's outstanding common stock, after giving effect to the offering, including V2X's repurchase of shares of its ...

V2X, Inc. (NYSE:VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2.0 million shares ...

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most ...

How did L-3 Vertex Aerospace spend their PAC money in the 2003-2004 election cycle? See the details.

Post-offering, Vertex Aerospace’s stake in V2X will reduce to approximately 38.4% of outstanding common stock, or 37.4% if the underwriter exercises its option to purchase an additional 300,000 shares ...

Following the offering, Vertex Aerospace will continue to beneficially own 12,167,286 shares, or approximately 38.4%, of V2X's outstanding common stock after giving effect to the offering (or ...

Following the offering, Vertex Aerospace will continue to beneficially own 12,167,286 shares, or approximately 38.4%, of V2X's outstanding common stock after giving effect to the offering (or ...

V2X, Inc. (NYSE: VVX) ("V2X"), a leading provider of global mission solutions, announced today the sale of 2 million shares of its common stock on an underwritten basis by Vertex Aerospace Holdco LLC ...

V2X is not selling any shares of common stock in the offering, and V2X will not receive any proceeds from the offering by Vertex Aerospace. The offering is expected to close on or about May 19 ...